Literature DB >> 30262509

Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?

Harriet Hunter.   

Abstract

Entities:  

Keywords:  adalimumab; etanercept; juvenile rheumatoid arthritis; rheumatology

Year:  2018        PMID： 30262509     DOI： 10.1136/archdischild-2018-315528

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  1 in total

1.  The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis.

Authors:  Jelena Bašić; Jelena Vojinović; Tatjana Jevtović-Stoimenov; Milena Despotović; Tatjana Cvetković; Dragana Lazarević; Gordana Sušić; Vuk Milošević; Mina Cvetković; Dušica Pavlović
Journal:  Rheumatol Int       Date:  2019-01-24       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.